Effect of Cryopreservation on SARS-CoV-2 Semen Samples: Influence of Two Different Cryopreservation Procedures Evaluated After Thawing
The study conducted by Istituto Clinico Humanitas addresses a critical gap in understanding the impact of SARS-CoV-2 on male reproductive health, particularly in the context of cryopreservation of semen. Given the increasing focus on fertility preservation amid the pandemic, this research could lead to the development of new protocols for semen cryopreservation that mitigate viral contamination risks. The findings may have significant implications for reproductive medicine and fertility clinics, potentially enhancing market offerings in fertility preservation services. Furthermore, the results could inform regulatory considerations and guidelines for handling biological samples in the context of viral infections, impacting competitive positioning in the reproductive health sector.
Indication: COVID 19
Modality: RNA therapy
Target: ACE2 and TMPRSS2 receptors on spermatozoa
Sponsor: Istituto Clinico Humanitas
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 18, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: ACE2 and TMPRSS2 receptors on spermatozoa
View original source fields
Condition raw: COVID 19
Condition normalized: COVID 19
Modality raw: RNA therapy
Modality normalized: RNA therapy
Target raw: ACE2 and TMPRSS2 receptors on spermatozoa
Target normalized: ACE2 and TMPRSS2 receptors on spermatozoa